- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RF ablation knocks out renal cell carcinoma
Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.
Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.
In the largest such study to date, the group followed 34 patients who had been treated with RF ablation for 42 renal cell carcinoma tumors during a 3.5-year period. They were able to completely ablate all of the 29 exophytic tumors and both parenchymal tumors in one or more visits. The mean diameter of the tumors was 3.2 cm. The team could completely ablate only five of the 11 tumors that had a component in the renal sinus, which acts as a heat sink by continuously allowing cool blood to flow into the area. The study was published in the February issue of Radiology.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
